NORTHEAST FINANCIAL CONSULTANTS INC – Vertex Pharmaceuticals Incorporated Transaction History
NORTHEAST FINANCIAL CONSULTANTS INC portfolio value:
$1.71M
portfolio value
NORTHEAST FINANCIAL CONSULTANTS INC quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -10.69% | -708 shares | -154K | $289.54 | 5.91K |
Q2 2022 | share | Decrease | -27.65% | -2.53K shares | -522K | $281.79 | 6.62K |
Q1 2022 | share | Increase | +5.52% | 479 shares | 484K | $260.97 | 9.15K |
Q4 2021 | share | Decrease | -5.09% | -465 shares | 247K | $222.45 | 8.67K |
Q3 2021 | share | Increase | +0.75% | 68 shares | -172K | $181.39 | 9.13K |
Q2 2021 | share | Increase | +0.59% | 53 shares | -108K | $201.63 | 9.06K |
Q1 2021 | share | Increase | +102.88% | 4.57K shares | 887K | $214.89 | 9.01K |
Q4 2020 | share | Decrease | -5.43% | -255 shares | -229K | $236.34 | 4.44K |
Q3 2020 | share | Increase | +0.09% | 4 shares | -84K | $272.12 | 4.69K |
Q2 2020 | share | Increase | +16.04% | 649 shares | 400K | $290.31 | 4.69K |
Q1 2020 | share | Increase | +1.89% | 75 shares | 94K | $237.95 | 4.04K |
Q4 2019 | share | Decrease | -3.64% | -150 shares | 171K | $218.95 | 3.97K |
Q3 2019 | share | 0.00% | 0 shares | -58K | $169.42 | 4.12K | |
Q2 2019 | share | 0.00% | 0 shares | -2K | $183.38 | 4.12K | |
Q1 2019 | share | Increase | 0.00% | 4.12K shares | 758K | $183.95 | 4.12K |
Q3 2018 | share | Decrease | -100.00% | -23.97K shares | -4.07M | $192.74 | 0 |
Q2 2018 | share | 0.00% | 0 shares | 168K | $169.96 | 23.97K | |
Q1 2018 | share | Decrease | -0.16% | -39 shares | 308K | $162.98 | 23.97K |
Q4 2017 | share | Increase | +0.16% | 39 shares | -47K | $149.86 | 24.01K |
Q3 2017 | share | 0.00% | 0 shares | 556K | $152.04 | 23.97K | |
Q2 2017 | share | 0.00% | 0 shares | 468K | $128.87 | 23.97K | |
Q1 2017 | share | 0.00% | 0 shares | 855K | $109.35 | 23.97K | |
Q4 2016 | share | Increase | +3.36% | 779 shares | -257K | $73.67 | 23.97K |
Q3 2016 | share | 0.00% | 0 shares | 28K | $87.21 | 23.19K | |
Q2 2016 | share | Decrease | -0.83% | -193 shares | 136K | $86.02 | 23.19K |
Q1 2016 | share | 0.00% | 0 shares | -1.08M | $79.49 | 23.38K |